LEADER 01103nam0 22002893i 450 
001 VAN00131657
005 20240806100834.709
010   $a978-36-624-4005-6
017 70$2N$a9783662440063
100   $a20201105d2015       |0itac50      ba
101   $aeng
102   $aDE
105   $a||||    |||||
200 1 $aCancer Immunology$eA Translational Medicine Context $fNima Rezaei editor
210   $aHeidelberg$cSpringer$d2015
215   $axlvii, 597 p.$d24 cm
620   $aDE$dHeidelberg$3VANL000282
702  1$aRezaei$bNima$3VANV085962
712   $aSpringer <editore>$3VANV108073$4650
801   $aIT$bSOL$c20240906$gRICA
856 4 $uhttps://link.springer.com/book/10.1007%2F978-3-662-44006-3$zE-book ? Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth
899   $aBIBLIOTECA CENTRO DI SERVIZIO SBA$2VAN15
912   $fN
912   $aVAN00131657
950   $aBIBLIOTECA CENTRO DI SERVIZIO SBA$d15CONS      SBA EBOOK 7487                      $e15EB 7487              20201105            
996   $aCancer Immunology$91760493
997   $aUNICAMPANIA